M Health Fairview Cancer Care has been a world leader in treating blood cancers like multiple myeloma with blood and marrow transplant (BMT) since 1968, when the world’s first successful BMT was completed here.
Multiple myeloma is a cancer that begins in the bone marrow and affects white blood cells called plasma cells. Healthy plasma cells create antibodies that fight off germs and infections. When the plasma cells become abnormal (myeloma cells), they cease to perform their usual function and begin to reproduce out of control. Excessive numbers of myeloma cells collect within the bone marrow and crowd out the normal white cells, red cells, and platelets.
Our approach
Physicians with M Health Fairview Cancer Care make up an internationally recognized team known for its innovative and compassionate care for patients with blood cancers such as multiple myeloma. Many treatments that are now available to patients around the world were pioneered at our National Cancer Institute-designated research center: Masonic Cancer Center, University of Minnesota.
M Health Fairview Cancer Care has been a world leader in treating blood cancers like multiple myeloma with blood and marrow transplant (BMT) since 1968, when the world’s first successful BMT was completed here. Since then, our physicians have performed roughly 6,000 transplants for patients with leukemia, lymphoma, myeloma, and other cancers of the blood.
We continue to perform leading-edge research in collaboration with scientists at the Masonic Cancer Center. This research often benefits patients who have failed standard therapies.
